Hikma Pharmaceuticals Plc Stock Volatility
| HKMPF Stock | USD 24.47 1.91 8.47% |
Hikma Pharmaceuticals PLC holds Efficiency (Sharpe) Ratio of -0.0576, which attests that the entity had a -0.0576% return per unit of risk over the last 3 months. Hikma Pharmaceuticals PLC exposes twenty different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check out Hikma Pharmaceuticals' Standard Deviation of 1.42, risk adjusted performance of (0.04), and Market Risk Adjusted Performance of (0.44) to validate the risk estimate we provide. Key indicators related to Hikma Pharmaceuticals' volatility include:
30 Days Market Risk | Chance Of Distress | 30 Days Economic Sensitivity |
Hikma Pharmaceuticals Pink Sheet volatility depicts how high the prices fluctuate around the mean (or its average) price. In other words, it is a statistical measure of the distribution of Hikma daily returns, and it is calculated using variance and standard deviation. We also use Hikma's beta, its sensitivity to the market, as well as its odds of financial distress to provide a more practical estimation of Hikma Pharmaceuticals volatility.
Hikma |
Since volatility provides investors with entry points to take advantage of stock prices, companies, such as Hikma Pharmaceuticals can benefit from it. Downward market volatility can be a perfect environment for investors who play the long game as hey may decide to buy additional stocks of Hikma Pharmaceuticals at lower prices to lower their average cost per share. Similarly, when the prices of Hikma Pharmaceuticals' stock rise, investors can sell out and invest the proceeds in other equities with better opportunities.
Moving together with Hikma Pink Sheet
| 0.86 | MKKGY | Merck KGaA ADR | PairCorr |
| 0.83 | MKGAF | MERCK Kommanditgesells | PairCorr |
| 0.78 | HLN | Haleon plc | PairCorr |
| 0.83 | TAK | Takeda Pharmaceutical | PairCorr |
| 0.73 | HLNCF | Haleon plc | PairCorr |
| 0.66 | TEVA | Teva Pharma Industries | PairCorr |
Moving against Hikma Pink Sheet
| 0.86 | PLTR | Palantir Technologies Aggressive Push | PairCorr |
| 0.74 | AXP | American Express Fiscal Year End 24th of January 2025 | PairCorr |
| 0.58 | GLABF | Gemina Laboratories | PairCorr |
Hikma Pharmaceuticals Market Sensitivity And Downside Risk
Hikma Pharmaceuticals' beta coefficient measures the volatility of Hikma pink sheet compared to the systematic risk of the entire market represented by your selected benchmark. In mathematical terms, beta represents the slope of the line through a regression of data points where each of these points represents Hikma pink sheet's returns against your selected market. In other words, Hikma Pharmaceuticals's beta of 0.2 provides an investor with an approximation of how much risk Hikma Pharmaceuticals pink sheet can potentially add to one of your existing portfolios. Hikma Pharmaceuticals PLC exhibits very low volatility with skewness of 1.92 and kurtosis of 25.31. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Hikma Pharmaceuticals' pink sheet risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Hikma Pharmaceuticals' pink sheet price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.
3 Months Beta |Analyze Hikma Pharmaceuticals PLC Demand TrendCheck current 90 days Hikma Pharmaceuticals correlation with market (Dow Jones Industrial)Hikma Beta |
Hikma standard deviation measures the daily dispersion of prices over your selected time horizon relative to its mean. A typical volatile entity has a high standard deviation, while the deviation of a stable instrument is usually low. As a downside, the standard deviation calculates all uncertainty as risk, even when it is in your favor, such as above-average returns.
Standard Deviation | 1.45 |
It is essential to understand the difference between upside risk (as represented by Hikma Pharmaceuticals's standard deviation) and the downside risk, which can be measured by semi-deviation or downside deviation of Hikma Pharmaceuticals' daily returns or price. Since the actual investment returns on holding a position in hikma pink sheet tend to have a non-normal distribution, there will be different probabilities for losses than for gains. The likelihood of losses is reflected in the downside risk of an investment in Hikma Pharmaceuticals.
Hikma Pharmaceuticals PLC Pink Sheet Volatility Analysis
Volatility refers to the frequency at which Hikma Pharmaceuticals pink sheet price increases or decreases within a specified period. These fluctuations usually indicate the level of risk that's associated with Hikma Pharmaceuticals' price changes. Investors will then calculate the volatility of Hikma Pharmaceuticals' pink sheet to predict their future moves. A pink sheet that has erratic price changes quickly hits new highs, and lows are considered highly volatile. A pink sheet with relatively stable price changes has low volatility. A highly volatile pink sheet is riskier, but the risk cuts both ways. Investing in highly volatile security can either be highly successful, or you may experience significant failure. There are two main types of Hikma Pharmaceuticals' volatility:
Historical Volatility
This type of pink sheet volatility measures Hikma Pharmaceuticals' fluctuations based on previous trends. It's commonly used to predict Hikma Pharmaceuticals' future behavior based on its past. However, it cannot conclusively determine the future direction of the pink sheet.Implied Volatility
This type of volatility provides a positive outlook on future price fluctuations for Hikma Pharmaceuticals' current market price. This means that the pink sheet will return to its initially predicted market price. This type of volatility can be derived from derivative instruments written on Hikma Pharmaceuticals' to be redeemed at a future date.Transformation |
The output start index for this execution was zero with a total number of output elements of sixty-one. Hikma Pharmaceuticals PLC Average Price is the average of the sum of open, high, low and close daily prices of a bar. It can be used to smooth an indicator that normally takes just the closing price as input.
Hikma Pharmaceuticals Projected Return Density Against Market
Assuming the 90 days horizon Hikma Pharmaceuticals has a beta of 0.2009 . This usually indicates as returns on the market go up, Hikma Pharmaceuticals average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Hikma Pharmaceuticals PLC will be expected to be much smaller as well.Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Hikma Pharmaceuticals or Healthcare sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Hikma Pharmaceuticals' price will be affected by overall pink sheet market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Hikma pink sheet's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
Hikma Pharmaceuticals PLC has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. Predicted Return Density |
| Returns |
What Drives a Hikma Pharmaceuticals Price Volatility?
Several factors can influence a pink sheet's market volatility:Industry
Specific events can influence volatility within a particular industry. For instance, a significant weather upheaval in a crucial oil-production site may cause oil prices to increase in the oil sector. The direct result will be the rise in the stock price of oil distribution companies. Similarly, any government regulation in a specific industry could negatively influence stock prices due to increased regulations on compliance that may impact the company's future earnings and growth.Political and Economic environment
When governments make significant decisions regarding trade agreements, policies, and legislation regarding specific industries, they will influence stock prices. Everything from speeches to elections may influence investors, who can directly influence the stock prices in any particular industry. The prevailing economic situation also plays a significant role in stock prices. When the economy is doing well, investors will have a positive reaction and hence, better stock prices and vice versa.The Company's Performance
Sometimes volatility will only affect an individual company. For example, a revolutionary product launch or strong earnings report may attract many investors to purchase the company. This positive attention will raise the company's stock price. In contrast, product recalls and data breaches may negatively influence a company's stock prices.Hikma Pharmaceuticals Pink Sheet Risk Measures
Assuming the 90 days horizon the coefficient of variation of Hikma Pharmaceuticals is -1734.98. The daily returns are distributed with a variance of 2.1 and standard deviation of 1.45. The mean deviation of Hikma Pharmaceuticals PLC is currently at 0.42. For similar time horizon, the selected benchmark (Dow Jones Industrial) has volatility of 0.76
α | Alpha over Dow Jones | -0.12 | |
β | Beta against Dow Jones | 0.20 | |
σ | Overall volatility | 1.45 | |
Ir | Information ratio | -0.15 |
Hikma Pharmaceuticals Pink Sheet Return Volatility
Hikma Pharmaceuticals historical daily return volatility represents how much of Hikma Pharmaceuticals pink sheet's daily returns swing around its mean - it is a statistical measure of its dispersion of returns. The company shows 1.4501% volatility of returns over 90 . By contrast, Dow Jones Industrial accepts 0.7502% volatility on return distribution over the 90 days horizon. Performance |
| Timeline |
About Hikma Pharmaceuticals Volatility
Volatility is a rate at which the price of Hikma Pharmaceuticals or any other equity instrument increases or decreases for a given set of returns. It is measured by calculating the standard deviation of the annualized returns over a given period of time and shows the range to which the price of Hikma Pharmaceuticals may increase or decrease. In other words, similar to Hikma's beta indicator, it measures the risk of Hikma Pharmaceuticals and helps estimate the fluctuations that may happen in a short period of time. So if prices of Hikma Pharmaceuticals fluctuate rapidly in a short time span, it is termed to have high volatility, and if it swings slowly in a more extended period, it is understood to have low volatility.
Please read more on our technical analysis page.Hikma Pharmaceuticals PLC develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharmaceutical products. The company was founded in 1978 and is based in London, the United Kingdom. Hikma Pharmaceutical operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 8700 people.
Hikma Pharmaceuticals' stock volatility refers to the amount of uncertainty or risk involved with the size of changes in its stock's price. It is a statistical measure of the dispersion of returns on Hikma Pink Sheet over a specified period of time, often expressed as the standard deviation of daily returns. In other words, it measures how much Hikma Pharmaceuticals' price varies over time.
3 ways to utilize Hikma Pharmaceuticals' volatility to invest better
Higher Hikma Pharmaceuticals' stock volatility means that the price of its stock is changing rapidly and unpredictably, while lower stock volatility indicates that the price of Hikma Pharmaceuticals PLC stock is relatively stable. Investors and traders use stock volatility as an indicator of risk and potential reward, as stocks with higher volatility can offer the potential for more significant returns but also come with a greater risk of losses. Hikma Pharmaceuticals PLC stock volatility can provide helpful information for making investment decisions in the following ways:- Measuring Risk: Volatility can be used as a measure of risk, which can help you determine the potential fluctuations in the value of Hikma Pharmaceuticals PLC investment. A higher volatility means higher risk and potentially larger changes in value.
- Identifying Opportunities: High volatility in Hikma Pharmaceuticals' stock can indicate that there is potential for significant price movements, either up or down, which could present investment opportunities.
- Diversification: Understanding how the volatility of Hikma Pharmaceuticals' stock relates to your other investments can help you create a well-diversified portfolio of assets with varying levels of risk.
Hikma Pharmaceuticals Investment Opportunity
Hikma Pharmaceuticals PLC has a volatility of 1.45 and is 1.93 times more volatile than Dow Jones Industrial. Compared to the overall equity markets, volatility of historical daily returns of Hikma Pharmaceuticals PLC is lower than 12 percent of all global equities and portfolios over the last 90 days. You can use Hikma Pharmaceuticals PLC to enhance the returns of your portfolios. The pink sheet experiences a very speculative upward sentiment. The trend is possibly hyped up. Check odds of Hikma Pharmaceuticals to be traded at $30.59 in 90 days.Average diversification
The correlation between Hikma Pharmaceuticals PLC and DJI is 0.11 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Hikma Pharmaceuticals PLC and DJI in the same portfolio, assuming nothing else is changed.
Hikma Pharmaceuticals Additional Risk Indicators
The analysis of Hikma Pharmaceuticals' secondary risk indicators is one of the essential steps in making a buy or sell decision. The process involves identifying the amount of risk involved in Hikma Pharmaceuticals' investment and either accepting that risk or mitigating it. Along with some common measures of Hikma Pharmaceuticals pink sheet's risk such as standard deviation, beta, or value at risk, we also provide a set of secondary indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Risk Adjusted Performance | (0.04) | |||
| Market Risk Adjusted Performance | (0.44) | |||
| Mean Deviation | 0.404 | |||
| Coefficient Of Variation | (1,775) | |||
| Standard Deviation | 1.42 | |||
| Variance | 2.01 | |||
| Information Ratio | (0.15) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential pink sheets, we recommend comparing similar pink sheets with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Hikma Pharmaceuticals Suggested Diversification Pairs
Pair trading is one of the very effective strategies used by professional day traders and hedge funds capitalizing on short-time and mid-term market inefficiencies. The approach is based on the fact that the ratio of prices of two correlating shares is long-term stable and oscillates around the average value. If the correlation ratio comes outside the common area, you can speculate with a high success rate that the ratio will return to the mean value and collect a profit.
The effect of pair diversification on risk is to reduce it, but we should note this doesn't apply to all risk types. When we trade pairs against Hikma Pharmaceuticals as a counterpart, there is always some inherent risk that will never be diversified away no matter what. This volatility limits the effect of tactical diversification using pair trading. Hikma Pharmaceuticals' systematic risk is the inherent uncertainty of the entire market, and therefore cannot be mitigated even by pair-trading it against the equity that is not highly correlated to it. On the other hand, Hikma Pharmaceuticals' unsystematic risk describes the types of risk that we can protect against, at least to some degree, by selecting a matching pair that is not perfectly correlated to Hikma Pharmaceuticals PLC.
Complementary Tools for Hikma Pink Sheet analysis
When running Hikma Pharmaceuticals' price analysis, check to measure Hikma Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Hikma Pharmaceuticals is operating at the current time. Most of Hikma Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Hikma Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Hikma Pharmaceuticals' price. Additionally, you may evaluate how the addition of Hikma Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Stocks Directory Find actively traded stocks across global markets | |
| Bonds Directory Find actively traded corporate debentures issued by US companies |